1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Demographics
ControlNPSLESLEP Value
Sample size201919–
Age (yr)40.1 ± 14.644.2 ± 13.441.9 ± 14.1.822
Disease duration (yr)–18.0 ± 10.117.4 ± 9.3.954
Cumulative prednisolone dosage (g)–53.8 ± 39.848.9 ± 28.9.317
Radiologic abnormalities (prevalence) (%)
    Lacunar infarct–2111.179
    Chronic infarct–1611.350
    Microbleeds–11111.000
Neuropsychiatric symptoms (prevalence) (%)
    Seizure–53––
    Confusion–21––
    Stroke–16––
    Psychosis–11––
    Cognitive impairment–5––
  • Note:— – indicates not applicable.